Michael Konstan, MD, Pediatric Pulmonology, Cleveland, OH, UH Cleveland Medical Center

MichaelWKonstanMD

Pediatric Pulmonology Cleveland, OH

Professor of Pediatrics, Case West Res Univ

Dr. Konstan is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Konstan's full profile

Already have an account?

Education & Training

  • Case Western Reserve University - University HospitalsFellowship, Pulmonary Disease, 1985 - 1988
  • Kaleida Health System - Children HospitalResidency, Pediatrics, 1982 - 1985
  • Case Western Reserve University School of MedicineClass of 1982

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1982 - 2022
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2004-2014
  • Northern Ohio Live Castle Connolly, 2006-2009

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AzurRx BioPharma Announces Formation of Scientific Advisory Board
    AzurRx BioPharma Announces Formation of Scientific Advisory BoardOctober 21st, 2020
  • Laurent Pharmaceuticals Receives an Additional up to $3M Award from Cystic Fibrosis Foundation
    Laurent Pharmaceuticals Receives an Additional up to $3M Award from Cystic Fibrosis FoundationOctober 31st, 2019
  • AzurRx BioPharma Announces Promising Results from Trial Testing MS1819 for EPI in CF Patients
    AzurRx BioPharma Announces Promising Results from Trial Testing MS1819 for EPI in CF PatientsSeptember 27th, 2019
  • Join now to see all

Grant Support

  • Research Career Development In Child HealthEunice Kennedy Shriver National Institute Of Child Health &Human Development2011–2012
  • Clinical StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
  • PTC124 As An Oral Treatment For Nonsense-Mutation-Mediated Cystic FibrosisNational Center For Research Resources2006
  • Tobramycin For Inhalation (TOBI) In Young Children With Cystic FibrosisNational Center For Research Resources2005
  • Oral Theraclec-Total In CF Patients With Exocrine Pancreatic InsufficiencyNational Center For Research Resources2005
  • Biil284bs In Adult And Pediatric Cystic Fibrosis PatientsNational Center For Research Resources2004–2005
  • Oral Theraclec-Total In Adult And Pediatric Subjects With Cystic FibrosisNational Center For Research Resources2004
  • Neutrophil Imaging Of The Lung For Characterizing Pulmonary Infection In CF PTSNational Center For Research Resources2004
  • Fat And Protein Absorption In Cystic Fibrosis PTS With Pancreatic InsufficiencyNational Center For Research Resources2004
  • Lower Airway Deposit Of Inhaled Tobramycin In Cystic FibNational Center For Research Resources2000–2002
  • Ins365 In Adult &Pediatric Cystic FibrosisNational Center For Research Resources2000–2002
  • Ib367 In Adult Patients With Cystic FibrosisNational Center For Research Resources2000–2002
  • Free Elastase Concentration In BAL Fluid In Cystic FibrosisNational Center For Research Resources2000–2002
  • Lung Specific Bioefficacy Of Oral DMP 777 In Adults W/ CFNational Center For Research Resources1999–2002
  • CPX (Oral, Multidose) In Adults W/ Mild To Moderately Severe Cystic FNational Center For Research Resources1999–2002
  • Dmp777 In Adult Patients 18 Yrs Of Age And Older With Cystic FibrosisNational Center For Research Resources1998–2000
  • CPX In Adult Patients With Mild Cystic FibrosisNational Center For Research Resources1998–2000
  • Prolastin Aerosol Therapy In Patients With Cystic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000
  • In Vivo Studies Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1994–2000
  • Trial In Patients With Mild Cystic Fibrosis To Determine Efficacy Of PulmozymeNational Center For Research Resources1996–1997
  • Bronchoalveolar Lavage Studies In Cystic FibrosisNational Center For Research Resources1996–1997
  • Inhalation Administration Of Alpha1-Pl By Aerosol In Cystic FibrosisNational Center For Research Resources1996
  • In Vivo Studies Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1992–1996
  • Pharmacokinetics Of Tobramycin Administered By Different Nebulizers To CF PTSNational Center For Research Resources1995
  • Pilot Study--Antiproteases And The Treatment Of Inflammation Of The Lung In CFNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1995
  • Intravenous ICI 200,880 In Stable Cystic Fibrosis OutpatientsNational Center For Research Resources1994
  • Clinical Trial Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1994
  • Secretory Leukocyte Protease Inhibitor Augmentation Therapy In CF PatientsNational Center For Research Resources1993
  • Intravenous Elastase Inhibitor In Stable Cyctic Fibrosis OutpatientsNational Center For Research Resources1993
  • Intravenous ICI 200,880 In Stable Cystic Fibrosis OutpatientsNational Center For Research Resources1992–1993
  • Clinical Trial Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1990–1993
  • Pilot Study-- Antiproteases And The Treatment Of Inflammation Of The Lung In CFNational Institute Of Diabetes And Digestive And Kidney Diseases1991

Hospital Affiliations